.Pharmacolibrary.Drugs.C_CardiovascularSystem.C09B_AceInhibitorsCombinations.C09BB02_EnalaprilAndLercanidipin.EnalaprilAndLercanidipin .Pharmacolibrary.Drugs.C_CardiovascularSystem.C09B_AceInhibitorsCombinations.C09BB02_EnalaprilAndLercanidipin.EnalaprilAndLercanidipin| name: | EnalaprilAndLercanidipine | |
| ATC code: | C09BB02 | route: | oral |
| compartments: | 1 | |
| dosage: | 20 | mg |
| volume of distribution: | 100 | L |
| clearance: | 40 | L/h |
| other parameters in model implementation | ||
Fixed-dose combination of enalapril, an angiotensin-converting enzyme (ACE) inhibitor, and lercanidipine, a dihydropyridine calcium channel blocker. Used for the treatment of essential hypertension in adults. The combination is approved and used clinically in several countries for better blood pressure control.
Estimated pharmacokinetic parameters for fixed-dose oral administration in adults, as no specific pharmacokinetic model for the combination are reported in published literature.